Glycoprotein E (VZV)

Glycoprotein E (VZV)

Glycoprotein E (VZV) 詳細

Molecule Name
Envelope (E) protein
分子の別称
gE
Drug Development Progress
治験薬の数2
市販薬剤の数0
研究&開発段階Phase 1 Clinical
ターゲットの別称
gE-1,Envelope glycoprotein E,gE

お問い合わせ

FAQ

What should be matched before selecting a gE assay?

Check species, assay purpose, antigen format, and whether the readout is antigen detection or antibody titer.

Does the gE kit measure viral load?

The listed kits are antibody or antigen ELISA tools; they are not described as viral-load assays.

Can VZV gE reagents support vaccine research?

Yes. Recombinant gE, antigen ELISA kits, and antibody-titer kits support distinct antigen-characterization and immune-response endpoints.

Which antibody reagents are included?

Available options include anti-gE monoclonal antibodies, including an unconjugated and a biotinylated format.

Is a biotinylated gE protein available?

GLE-V82E3 is biotinylated VZV gE with His and AviTag.

Which gE assay kits are available?

Available options include VZV gE ELISA kits and mouse or human anti-VZV IgG-titer serology kits.

Why is VZV gE relevant to antibody research?

gE is an abundant, immunogenic glycoprotein on virus and infected-cell surfaces, making it relevant to antigen-specific antibody studies.

Which VZV gE antigen is available?

The portfolio includes gE from varicella-zoster virus strain Oka vaccine, expressed as a His-tagged recombinant protein.
Asset Licensing Opportunity
Resources

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
LHF-535LHF-535; LHF-535-SDDPhase 1 ClinicalKineta Inc
詳細
SAR-440894SAR-440894Phase 1 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)
Chikungunya Fever
詳細
Customer Reviews